or Try an Advanced Search...

    Combination Drugs Stocks List

    Symbol Grade Name % Change
    ABBV D AbbVie Inc. 3.04
    INVA D Innoviva, Inc. 0.47
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Adalimumab Advanced Prostate Cancer Anemia Antero Asthma Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Chronic Obstructive Pulmonary Disease Constipation Corticosteroid Crohn's Disease Depressive Disorder Drugs Endometriosis Eye Care Products Fluticasone Genotype Glucocorticoids

    Related ETFs - A few ETFs which own one or more of the above listed Combination Drugs stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.31
    PJP C PowerShares Dynamic Pharmaceuticals 8.28
    MEDX F Horizon Kinetics Medical ETF 7.81
    GRID C First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.75
    View all Combination Drugs ETFs...
    Compare ETFs
    Compare HDLB to BOTZ Compare PJP to GRID Compare PJP to MEDX

        Combination Drugs Stocks Recent News

        Date Stock Title
        Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
        Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
        Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
        Nov 22 INVA Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
        Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
        Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 19 ABBV Where Will AbbVie Be in 5 Years?
        Nov 19 ABBV RVPH: Year-End OLE Update
        Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
        Nov 18 ABBV AbbVie snaps eight straight sessions of losses
        Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
        Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
        Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
        Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
        Nov 18 ABBV AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Adalimumab Advanced Prostate Cancer Anemia Antero Asthma Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Chronic Obstructive Pulmonary Disease Constipation Corticosteroid Crohn's Disease Depressive Disorder Drugs Endometriosis Eye Care Products Fluticasone Genotype Glucocorticoids
        Combination Drugs

        Combination drugs are medications that contain two or more active ingredients in a single dosage form. These drugs are used to treat a variety of conditions, such as high blood pressure, diabetes, and asthma. Combination drugs can be more effective than taking multiple medications, as they can reduce the number of pills a patient needs to take and may also reduce side effects.

        Browse All Tags